{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:09:00Z","timestamp":1794294540777,"version":"4.9.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T00:00:00Z","timestamp":1691280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T00:00:00Z","timestamp":1691280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Candida auris<\/jats:italic>\n                      is an emerging yeast pathogen that can cause invasive infections, particularly candidemia, in healthcare settings.\n                      <jats:italic>Candida auris<\/jats:italic>\n                      is characterized by resistance to multiple classes of antifungal drugs and high mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To describe the risk factors, clinical characteristics, antifungal susceptibility pattern and outcomes of\n                      <jats:italic>Candida auris<\/jats:italic>\n                      blood stream infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective review of electronic medical records of\n                      <jats:italic>C. auris<\/jats:italic>\n                      fungemia cases in the facilities under Hamad Medical corporation, Qatar from 1\/11\/2018 to 31\/7\/2021. Demographic data, risk factors, antibiogram and 30-day outcome are described.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified 36 patients with\n                      <jats:italic>C. auris<\/jats:italic>\n                      fungemia. Most of the patients were in intensive care unit following severe COVID-19 pneumonia and had received steroids and broad-spectrum antibiotics. Most cases were central line related. Over 90% of isolates were non-susceptible to fluconazole, while amphotericin B resistance reached 85%. Factors associated with high mortality included initial SOFA score of 9 or above and absence of source control.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our study reveals a concerning 41.6% mortality rate within 30 days of\n                      <jats:italic>C. auris<\/jats:italic>\n                      candidemia. Furthermore, the prevalence of amphotericin B resistance in Qatar exceeds what has been reported in the literature necessitating further exploration. Echinocandins retains nearly 100% susceptibility and should be prioritized as the treatment of choice. These findings emphasize the need for vigilant monitoring and appropriate management strategies to combat\n                      <jats:italic>C. auris<\/jats:italic>\n                      infections and improve patient outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08477-5","type":"journal-article","created":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T08:01:17Z","timestamp":1691308877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Candida auris Blood stream infection- a descriptive study from Qatar"],"prefix":"10.1186","volume":"23","author":[{"given":"Junais","family":"Koleri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawabibee Mahir","family":"Petkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam Abdel","family":"Rahman S. Al Soub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna A.","family":"Rahman S. AlMaslamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,6]]},"reference":[{"issue":"1","key":"8477_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","volume":"53","author":"K Satoh","year":"2009","unstructured":"Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a japanese hospital. Microbiol Immunol. 2009;53(1):41\u20134.","journal-title":"Microbiol Immunol"},{"issue":"1","key":"8477_CR2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1186\/s12879-020-05543-0","volume":"20","author":"J Chen","year":"2020","unstructured":"Chen J, Tian S, Han X, Chu Y, Wang Q, Zhou B, et al. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC Infect Dis. 2020;20(1):827.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"8477_CR3","doi-asserted-by":"publisher","first-page":"e01588","DOI":"10.1128\/JCM.01588-17","volume":"56","author":"ES Spivak","year":"2018","unstructured":"Spivak ES, Hanson KE. Candida auris: an emerging Fungal Pathogen. J Clin Microbiol. 2018;56(2):e01588\u201317.","journal-title":"J Clin Microbiol"},{"key":"8477_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","volume":"5","author":"S Schelenz","year":"2016","unstructured":"Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a european hospital. Antimicrob Resist Infect Control. 2016;5:35.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"8477_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/ajt.14121","volume":"17","author":"S Vallabhaneni","year":"2017","unstructured":"Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the First Seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant Fungus-United States, May 2013-August 2016. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2017;17(1):296\u20139.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"2","key":"8477_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","volume":"64","author":"SR Lockhart","year":"2017","unstructured":"Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of Multidrug-Resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis Off Publ Infect Dis Soc Am. 2017;64(2):134\u201340.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"8477_CR7","doi-asserted-by":"publisher","first-page":"e00029","DOI":"10.1128\/CMR.00029-17","volume":"31","author":"A Jeffery-Smith","year":"2018","unstructured":"Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2018;31(1):e00029\u201317.","journal-title":"Clin Microbiol Rev"},{"issue":"S1","key":"8477_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1017\/ice.2020.789","volume":"41","author":"F Visan","year":"2020","unstructured":"Visan F, Ansari NA, Wali WA, Zakaria A, Hasanat OA, Castro J, et al. First Candida auris Outbreak experience in a tertiary-care General Hospital in Qatar, 2019. Infect Control Hosp Epidemiol. 2020;41(S1):235\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"8477_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/jof7030240","volume":"7","author":"H Salah","year":"2021","unstructured":"Salah H, Sundararaju S, Dalil L, Salameh S, Al-Wali W, Tang P, et al. Genomic epidemiology of Candida auris in Qatar reveals Hospital Transmission Dynamics and a south asian origin. J Fungi Basel Switz. 2021;7(3):240.","journal-title":"J Fungi Basel Switz"},{"key":"8477_CR10","unstructured":"Ben Abid F, Salah H, Sundararaju S, Dalil L, Abdelwahab AH, Salameh S et al. Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs. Clin Microbiol Infect [Internet]. 2023 Apr 26 [cited 2023 Jun 10]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10132836\/."},{"key":"8477_CR11","doi-asserted-by":"publisher","first-page":"e01007","DOI":"10.1016\/j.idcr.2020.e01007","volume":"23","author":"A Shaukat","year":"2021","unstructured":"Shaukat A, Al Ansari N, Al Wali W, Karic E, El Madhoun I, Mitwally H, et al. Experience of treating Candida auris cases at a general hospital in the state of Qatar. IDCases. 2021;23:e01007.","journal-title":"IDCases"},{"key":"8477_CR12","unstructured":"Clinical & Laboratory Standards Institute [Internet]. [cited 2022 Sep 16]. M27M44SEd3 | Performance Standards for Antifungal Susceptibility Testing of Yeasts, 3rd Edition. Available from: https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m27m44s\/."},{"key":"8477_CR13","unstructured":"Clinical & Laboratory Standards Institute [Internet]. [cited 2022 Sep 16]. M57SEd4 | Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 4th Edition. Available from: https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m57s\/."},{"key":"8477_CR14","unstructured":"Antifungal Susceptibility Testing and Interpretation. | Candida auris | Fungal Diseases | CDC [Internet]. 2023 [cited 2023 Jun 17]. Available from: https:\/\/www.cdc.gov\/fungal\/candida-auris\/c-auris-antifungal.html."},{"issue":"1","key":"8477_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5858\/arpa.2018-0508-RA","volume":"144","author":"DJ Hata","year":"2020","unstructured":"Hata DJ, Humphries R, Lockhart SR, College of American Pathologists Microbiology Committee. Candida auris: an emerging yeast Pathogen posing distinct Challenges for Laboratory Diagnostics, Treatment, and infection Prevention. Arch Pathol Lab Med. 2020;144(1):107\u201314.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"8477_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","volume":"41","author":"A Chakrabarti","year":"2015","unstructured":"Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 2015;41(2):285\u201395.","journal-title":"Intensive Care Med"},{"issue":"9","key":"8477_CR17","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1128\/JCM.00319-11","volume":"49","author":"WG Lee","year":"2011","unstructured":"Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49(9):3139\u201342.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"8477_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jinf.2016.07.008","volume":"73","author":"B Calvo","year":"2016","unstructured":"Calvo B, Melo ASA, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016;73(4):369\u201374.","journal-title":"J Infect"},{"issue":"12","key":"8477_CR19","doi-asserted-by":"publisher","first-page":"ofab452","DOI":"10.1093\/ofid\/ofab452","volume":"8","author":"E Rajni","year":"2021","unstructured":"Rajni E, Singh A, Tarai B, Jain K, Shankar R, Pawar K, et al. A high frequency of Candida auris Blood Stream Infections in Coronavirus Disease 2019 patients admitted to Intensive Care Units, Northwestern India: a Case Control Study. Open Forum Infect Dis. 2021;8(12):ofab452.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"8477_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/pathogens10020157","volume":"10","author":"F Allaw","year":"2021","unstructured":"Allaw F, Kara Zahreddine N, Ibrahim A, Tannous J, Taleb H, Bizri AR, et al. First Candida auris Outbreak during a COVID-19 pandemic in a tertiary-care Center in Lebanon. Pathogens. 2021;10(2):157.","journal-title":"Pathogens"},{"issue":"10","key":"8477_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/antibiotics9100638","volume":"9","author":"J Mohsin","year":"2020","unstructured":"Mohsin J, Weerakoon S, Ahmed S, Puts Y, Al Balushi Z, Meis JF, et al. A cluster of Candida auris Blood Stream Infections in a Tertiary Care Hospital in Oman from 2016 to 2019. Antibiotics. 2020;9(10):638.","journal-title":"Antibiotics"},{"issue":"4","key":"8477_CR22","doi-asserted-by":"publisher","first-page":"e00578","DOI":"10.1002\/mbo3.578","volume":"7","author":"J Osei Sekyere","year":"2018","unstructured":"Osei Sekyere J. Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug\u2010resistant pathogen. MicrobiologyOpen. 2018;7(4):e00578.","journal-title":"MicrobiologyOpen"},{"issue":"4","key":"8477_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/jof5040101","volume":"5","author":"A Al Maani","year":"2019","unstructured":"Al Maani A, Paul H, Al-Rashdi A, Al Wahaibi A, Al-Jardani A, Al Abri AMA, et al. Ongoing Challenges with Healthcare-Associated Candida auris Outbreaks in Oman. J Fungi. 2019;5(4):101.","journal-title":"J Fungi"},{"issue":"1","key":"8477_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/jof7010031","volume":"7","author":"A Al-Rashdi","year":"2021","unstructured":"Al-Rashdi A, Al-Maani A, Al-Wahaibi A, Alqayoudhi A, Al-Jardani A, Al-Abri S, Characteristics. Risk factors, and Survival Analysis of Candida auris cases: results of One-Year National Surveillance Data from Oman. J Fungi. 2021;7(1):31.","journal-title":"J Fungi"},{"issue":"5","key":"8477_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s15010-018-1164-y","volume":"46","author":"Z Khan","year":"2018","unstructured":"Khan Z, Ahmad S, Benwan K, Purohit P, Al-Obaid I, Bafna R, et al. Invasive Candida auris infections in Kuwait hospitals: epidemiology, antifungal treatment and outcome. Infection. 2018;46(5):641\u201350.","journal-title":"Infection"},{"issue":"7","key":"8477_CR26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/myc.12781","volume":"61","author":"A Ruiz-Gait\u00e1n","year":"2018","unstructured":"Ruiz-Gait\u00e1n A, Moret AM, Tasias-Pitarch M, Aleixandre-L\u00f3pez AI, Mart\u00ednez-Morel H, Calabuig E, et al. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care european hospital. Mycoses. 2018;61(7):498\u2013505.","journal-title":"Mycoses"},{"issue":"3","key":"8477_CR27","doi-asserted-by":"publisher","first-page":"e1436","DOI":"10.1093\/cid\/ciac735","volume":"76","author":"SP Simon","year":"2023","unstructured":"Simon SP, Li R, Silver M, Andrade J, Tharian B, Fu L, et al. Comparative outcomes of Candida auris Bloodstream Infections: a Multicenter Retrospective Case-Control Study. Clin Infect Dis. 2023;76(3):e1436\u201343.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"8477_CR28","doi-asserted-by":"publisher","first-page":"ofz262","DOI":"10.1093\/ofid\/ofz262","volume":"6","author":"MJ Biagi","year":"2019","unstructured":"Biagi MJ, Wiederhold NP, Gibas C, Wickes BL, Lozano V, Bleasdale SC, et al. Development of high-level Echinocandin Resistance in a patient with recurrent Candida auris Candidemia secondary to chronic Candiduria. Open Forum Infect Dis. 2019;6(7):ofz262.","journal-title":"Open Forum Infect Dis"},{"key":"8477_CR29","doi-asserted-by":"crossref","unstructured":"Briano F, Magnasco L, Sepulcri C, Dettori S, Dentone C, Mikulska M et al. Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors. Infect Dis Ther. 2022;11(3):1149\u201360.","DOI":"10.1007\/s40121-022-00625-9"},{"issue":"10223","key":"8477_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507\u201313.","journal-title":"The Lancet"},{"issue":"2","key":"8477_CR31","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.jinf.2020.08.005","volume":"82","author":"AMS Al-Hatmi","year":"2021","unstructured":"Al-Hatmi AMS, Mohsin J, Al-Huraizi A, Khamis F. COVID-19 associated invasive candidiasis. J Infect. 2021;82(2):e45\u20136.","journal-title":"J Infect"},{"issue":"2","key":"8477_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266\u201375.","journal-title":"J Infect"},{"issue":"3","key":"8477_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ajic.2021.11.015","volume":"50","author":"M Alsuhaibani","year":"2022","unstructured":"Alsuhaibani M, Kobayashi T, McPherson C, Holley S, Marra AR, Trannel A, et al. Impact of COVID-19 on an infection prevention and control program, Iowa 2020\u20132021. Am J Infect Control. 2022;50(3):277\u201382.","journal-title":"Am J Infect Control"},{"issue":"2","key":"8477_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/jof7020140","volume":"7","author":"V Di Pilato","year":"2021","unstructured":"Di Pilato V, Codda G, Ball L, Giacobbe DR, Willison E, Mikulska M, et al. Molecular Epidemiological Investigation of a nosocomial cluster of C. auris: evidence of recent emergence in Italy and ease of transmission during the COVID-19 pandemic. J Fungi. 2021;7(2):140.","journal-title":"J Fungi"},{"issue":"7","key":"8477_CR35","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/myc.13471","volume":"65","author":"N Vaseghi","year":"2022","unstructured":"Vaseghi N, Sharifisooraki J, Khodadadi H, Nami S, Safari F, Ahangarkani F, et al. Global prevalence and subgroup analyses of coronavirus disease (COVID-19) associated Candida auris infections (CACa): a systematic review and meta-analysis. Mycoses. 2022;65(7):683\u2013703.","journal-title":"Mycoses"},{"issue":"1","key":"8477_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13756-022-01085-z","volume":"11","author":"RM Kariyawasam","year":"2022","unstructured":"Kariyawasam RM, Julien DA, Jelinski DC, Larose SL, Rennert-May E, Conly JM, et al. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019\u2013June 2021). Antimicrob Resist Infect Control. 2022;11(1):45.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"12","key":"8477_CR37","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/mmy\/myab056","volume":"59","author":"AS Omrani","year":"2021","unstructured":"Omrani AS, Koleri J, Ben Abid F, Daghfel J, Odaippurath T, Peediyakkal MZ, et al. Clinical characteristics and risk factors for COVID-19-associated Candidemia. Med Mycol. 2021;59(12):1262\u20136.","journal-title":"Med Mycol"},{"issue":"1","key":"8477_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12879-020-05719-8","volume":"21","author":"N Asai","year":"2021","unstructured":"Asai N, Ohashi W, Sakanashi D, Suematsu H, Kato H, Hagihara M, et al. Combination of sequential organ failure Assessment (SOFA) score and Charlson Comorbidity Index (CCI) could predict the severity and prognosis of candidemia more accurately than the Acute Physiology, Age, Chronic Health evaluation II (APACHE II) score. BMC Infect Dis. 2021;21(1):77.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"8477_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jiac.2019.01.002","volume":"25","author":"H Kato","year":"2019","unstructured":"Kato H, Yoshimura Y, Suido Y, Shimizu H, Ide K, Sugiyama Y, et al. Mortality and risk factor analysis for Candida blood stream infection: a multicenter study. J Infect Chemother. 2019;25(5):341\u20135.","journal-title":"J Infect Chemother"},{"key":"8477_CR40","doi-asserted-by":"crossref","unstructured":"Ertunc B, Yilmaz G, Koksal I. The Importance of Scoring Systems in Patients with Candidemia. Med Mycol Open Access [Internet]. 2018 [cited 2022 Jun 22];4(1). Available from: https:\/\/mycology.imedpub.com\/abstract\/the-importance-of-scoring-systems-in-patients-with-candidemia-23970.html.","DOI":"10.21767\/2471-8521.100028"},{"issue":"6","key":"8477_CR41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10096-013-2027-1","volume":"33","author":"A Chowdhary","year":"2014","unstructured":"Chowdhary A, Anil Kumar V, Sharma C, Prakash A, Agarwal K, Babu R, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2014;33(6):919\u201326.","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"issue":"5","key":"8477_CR42","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/myc.13065","volume":"63","author":"RS Almaghrabi","year":"2020","unstructured":"Almaghrabi RS, Albalawi R, Mutabagani M, Atienza E, Aljumaah S, Gade L, et al. Molecular characterisation and clinical outcomes of Candida auris infection: single-centre experience in Saudi Arabia. Mycoses. 2020;63(5):452\u201360.","journal-title":"Mycoses"},{"issue":"4","key":"8477_CR43","doi-asserted-by":"publisher","first-page":"e0195743","DOI":"10.1371\/journal.pone.0195743","volume":"13","author":"Z Khan","year":"2018","unstructured":"Khan Z, Ahmad S, Al-Sweih N, Joseph L, Alfouzan W, Asadzadeh M. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. PLoS ONE. 2018;13(4):e0195743.","journal-title":"PLoS ONE"},{"issue":"4","key":"8477_CR44","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice Guideline for the management of Candidiasis: 2016 update by the infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1\u201350.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08477-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08477-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08477-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:09:59Z","timestamp":1700489399000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08477-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8477"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08477-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2730832\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,6]]},"assertion":[{"value":"24 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Potential competing Interests"}},{"value":"Study was approved by the Institutional Review Board, which is the ethical committee of Medical Research Center, Hamad medical corporation, Doha, Qatar. All experiments were performed in accordance with relevant guidelines and regulations (such as the Declaration of Helsinki).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as there is no patient identifiable data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication from study participants"}},{"value":"Exempted from written informed consent from study participants by the Institutional Review Board, which is the ethical committee of Medical Research Centre, Hamad medical corporation, Doha, Qatar.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Written informed consent from study participants"}}],"article-number":"513"}}